Skip to main content
Caplight Logo









Cadenza Bio

Cadenza Bio

Private
Oklahoma City, OklahomaHealthcare & Life Scienceshttps://www.cadenza.bio/

Last Round

Seed

Dec 14, 2023

Total Funding Raised

$2.44M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cadenza Bio is a biotechnology company that develops novel small-molecule drugs for demyelinating and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall molecule therapeuticspreclinical researchinflammatory diseasefibrotic diseasebiotech startuptherapeutic developmentdrug pipelinebiopharmapreclinical assetsdrug licensingearly-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cadenza Bio Comparables

Compare Cadenza Bio with similar companies based on industry and business-model similarity.

Cadenza Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Find Therapeutics
72%
Progentos Therapeutics
71%
Incyte Corporation
71%

Cadenza Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 14, 2023

Key People

Founding team and executive leadership

Carol Curtis

Co-Founder CEO

Founding Team

Cadenza Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 210% MoM, reaching 6.4K.

  • Feb 7, 2025

    Partnered with Tufts University to advance endometriosis program.

Cadenza Bio Filings

Explore SEC and related filing metadata, where available.

Cadenza Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cadenza Bio's valuation, stock price, and market status.

Is Cadenza Bio a public or private company?

Cadenza Bio is a private company.

What is the current stock price of Cadenza Bio?

Cadenza Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Cadenza Bio worth (valuation)?

Valuation information for Cadenza Bio is not publicly available.

Can I buy Cadenza Bio stock?

Cadenza Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cadenza Bio's last funding round?

Cadenza Bio's most recent funding round was Seed on December 14, 2023.

Who are the main investors in Cadenza Bio?

Key investors in Cadenza Bio include Plains Ventures.

Will Cadenza Bio IPO soon?

No public IPO plans have been announced for Cadenza Bio.

How can I track Cadenza Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cadenza Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOklahoma City, Oklahoma
Employee Range5
Year Founded2022
Last FundingDec 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?